SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Mansouri Larry) "

Sökning: WFRF:(Mansouri Larry)

  • Resultat 41-50 av 81
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
41.
  • Mansouri, Larry, et al. (författare)
  • Functional loss of I kappa B epsilon leads to NF-kappa B deregulation in aggressive chronic lymphocytic leukemia
  • 2015
  • Ingår i: Journal of Experimental Medicine. - : Rockefeller University Press. - 0022-1007 .- 1540-9538. ; 212:6, s. 833-843
  • Tidskriftsartikel (refereegranskat)abstract
    • NF-kappa B is constitutively activated in chronic lymphocytic leukemia (CLL); however, the implicated molecular mechanisms remain largely unknown. Thus, we performed targeted deep sequencing of 18 core complex genes within the NF-kappa B pathway in a discovery and validation CLL cohort totaling 315 cases. The most frequently mutated gene was NFKBIE (21/315 cases; 7%), which encodes I kappa B epsilon, a negative regulator of NF-kappa B in normal B cells. Strikingly, 13 of these cases carried an identical 4-bp frameshift deletion, resulting in a truncated protein. Screening of an additional 377 CLL cases revealed that NFKBIE aberrations predominated in poor-prognostic patients and were associated with inferior outcome. Minor subclones and/or clonal evolution were also observed, thus potentially linking this recurrent event to disease progression. Compared with wild-type patients, NFKBIE-deleted cases showed reduced I kappa B epsilon protein levels and decreased p65 inhibition, along with increased phosphorylation and nuclear translocation of p65. Considering the central role of B cell receptor (BcR) signaling in CLL pathobiology, it is notable that I kappa B epsilon loss was enriched in aggressive cases with distinctive stereotyped BcR, likely contributing to their poor prognosis, and leading to an altered response to BcR inhibitors. Because NFKBIE deletions were observed in several other B cell lymphomas, our findings suggest a novel common mechanism of NF-kappa B deregulation during lymphomagenesis.
  •  
42.
  • Mansouri, Larry, et al. (författare)
  • Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
  • 2015
  • Ingår i: Journal of Experimental Medicine. - : Rockefeller University Press. - 1540-9538 .- 0022-1007. ; 212:6, s. 833-843
  • Tidskriftsartikel (refereegranskat)abstract
    • NF-κB is constitutively activated in chronic lymphocytic leukemia (CLL); however, the implicated molecular mechanisms remain largely unknown. Thus, we performed targeted deep sequencing of 18 core complex genes within the NF-κB pathway in a discovery and validation CLL cohort totaling 315 cases. The most frequently mutated gene was NFKBIE (21/315 cases; 7%), which encodes IκBε, a negative regulator of NF-κB in normal B cells. Strikingly, 13 of these cases carried an identical 4-bp frameshift deletion, resulting in a truncated protein. Screening of an additional 377 CLL cases revealed that NFKBIE aberrations predominated in poor-prognostic patients and were associated with inferior outcome. Minor subclones and/or clonal evolution were also observed, thus potentially linking this recurrent event to disease progression. Compared with wild-type patients, NFKBIE-deleted cases showed reduced IκBε protein levels and decreased p65 inhibition, along with increased phosphorylation and nuclear translocation of p65. Considering the central role of B cell receptor (BcR) signaling in CLL pathobiology, it is notable that IκBε loss was enriched in aggressive cases with distinctive stereotyped BcR, likely contributing to their poor prognosis, and leading to an altered response to BcR inhibitors. Because NFKBIE deletions were observed in several other B cell lymphomas, our findings suggest a novel common mechanism of NF-κB deregulation during lymphomagenesis.
  •  
43.
  •  
44.
  • Mansouri, Larry, et al. (författare)
  • Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia
  • 2012
  • Ingår i: American Journal of Hematology. - : Wiley. - 0361-8609 .- 1096-8652. ; 87:7, s. 737-740
  • Tidskriftsartikel (refereegranskat)abstract
    • Advances in next-generation RNA-sequencing have revealed the complexity of transcriptomes by allowing both coding and noncoding (nc) RNAs to be analyzed. However, limited data exist regarding the whole transcriptional landscape of chronic lymphocytic leukemia (CLL). In this pilot-study, we evaluated RNA-sequencing in CLL by comparing two subsets which carry almost identical or `` stereotyped'' B-cell receptors with distinct clinical outcome, that is the poor-prognostic subset # 1 (n = 4) and the more favorable-prognostic subset # 4 (n = 4). Our analysis revealed that 156 genes (e.g. LPL, WNT9A) and 76 ncRNAs, (e. g. SNORD48, SNORD115) were differentially expressed between the subsets. This technology also enabled us to identify numerous subset-specific splice variants (n = 406), which were predominantly expressed in subset # 1, including a splice-isoform of MSI2 with a novel start exon. A further important application of RNA-sequencing was for mutation detection and revealed 16-30 missense mutations per sample; notably many of these changes were found in genes with a strong potential for involvement in CLL pathogenesis, e. g., ATM and NOTCH2. This study not only demonstrates the effectiveness of RNA-sequencing for identifying mutations, quantifying gene expression and detecting splicing events, but also highlights the potential such global approaches have to significantly advance our understanding of the molecular mechanisms behind CLL development. 
  •  
45.
  • Mansouri, Larry, et al. (författare)
  • NF-kappa B activation in chronic lymphocytic leukemia : A point of convergence of external triggers and intrinsic lesions
  • 2016
  • Ingår i: Seminars in Cancer Biology. - : Elsevier BV. - 1044-579X .- 1096-3650. ; 39, s. 40-48
  • Forskningsöversikt (refereegranskat)abstract
    • The nuclear factor-kappa B (NF-kappa B) pathway is constitutively activated in chronic lymphocytic leukemia (CLL) patients, and hence plays a major role in disease development and evolution. In contrast to many other mature B-cell lymphomas, only a few recurrently mutated genes involved in canonical or non-canonical NF-kappa B activation have been identified in CLL (i.e. BIRC3, MYD88 and NFKBIE mutations) and often at a low frequency. On the other hand, CLL B cells seem 'addicted' to the tumor microenvironment for their survival and proliferation, which is primarily mediated by interaction through a number of cell surface receptors, e.g. the B-cell receptor (BcR), Toll-like receptors and CD40, that in turn activate downstream NF-kappa B. The importance of cell-extrinsic triggering for CLL pathophysiology was recently also highlighted by the clinical efficacy of novel drugs targeting microenvironmental interactions through the inhibition of BcR signaling. In other words, CLL can be considered a prototype disease for studying the intricate interplay between external triggers and intrinsic aberrations and their combined impact on disease evolution. In this review, we will discuss the current understanding of mechanisms underlying NF-kappa B deregulation in CLL, including micro-environmental, genetic and epigenetic events, and summarize data generated in murine models resembling human CLL. Finally, we will also discuss different strategies undertaken to intervene with the NF-kappa B pathway and its upstream mediators.
  •  
46.
  •  
47.
  •  
48.
  • Mansouri, Larry, et al. (författare)
  • Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
  • 2013
  • Ingår i: American Journal of Hematology. - : Wiley. - 0361-8609 .- 1096-8652. ; 88:8, s. 647-651
  • Tidskriftsartikel (refereegranskat)abstract
    • Most previous studies on telomere length (TL) in chronic lymphocytic leukemia (CLL) are based on referral cohorts including a high proportion of aggressive cases. Here, the impact of TL was analyzed in a population-based cohort of newly diagnosed CLL (n=265) and in relation to other prognostic markers. Short telomeres were particularly associated with high-risk genetic markers, such as NOTCH1, SF3B1, or TP53 aberrations, and predicted a short time to treatment (TTT) and overall survival (OS) (both P<0.0001). TL was an independent prognostic factor and subdivided patients with otherwise good-prognostic features (e.g., mutated IGHV genes, favorable cytogenetics) into subgroups with different outcome. Furthermore, in follow-up samples (n=119) taken 5-8 years after diagnosis, TL correlated well with TL at diagnosis and remained unaffected by treatment. Altogether, these novel data indicate that short TL already at diagnosis is associated with poor outcome in CLL and that TL can be measured at later stages of the disease. 
  •  
49.
  •  
50.
  • Mansouri, Larry, et al. (författare)
  • Unraveling the DNA Methylome in Mantle Cell Lymphoma : New Insights into the Cellular Origin
  • 2016
  • Ingår i: Cancer Cell. - : Elsevier BV. - 1535-6108 .- 1878-3686. ; 30:5, s. 665-667
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Our understanding of the DNA methylome and its impact on cancer evolution and disease progression is rapidly evolving. In this issue of Cancer Cell, Queiros et al. provide a detailed characterization of the DNA methylome in mantle cell lymphoma and reveal novel molecular subtypes, potentially with different cellular origins.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 41-50 av 81
Typ av publikation
tidskriftsartikel (64)
konferensbidrag (6)
annan publikation (4)
forskningsöversikt (4)
doktorsavhandling (3)
Typ av innehåll
refereegranskat (56)
övrigt vetenskapligt/konstnärligt (25)
Författare/redaktör
Mansouri, Larry (78)
Rosenquist, Richard (61)
Stamatopoulos, Kosta ... (34)
Juliusson, Gunnar (33)
Sutton, Lesley-Ann (30)
Ghia, Paolo (25)
visa fler...
Pospisilova, Sarka (25)
Plevova, Karla (23)
Baliakas, Panagiotis (22)
Smedby, Karin E. (19)
Belessi, Chrysoula (19)
Young, Emma (19)
Davi, Frederic (18)
Oscier, David (18)
Langerak, Anton W. (17)
Gunnarsson, Rebeqa (15)
Davis, Zadie (14)
Cortese, Diego (14)
Chiorazzi, Nicholas (13)
Rossi, Davide (13)
Gaidano, Gianluca (13)
Bhoi, Sujata (13)
Ljungström, Viktor (13)
Isaksson, Anders (11)
Pospisilova, S (11)
Ghia, P (11)
Agathangelidis, Andr ... (11)
Scarfo, Lydia (11)
Panagiotidis, Panagi ... (11)
Campo, Elias (10)
Belessi, C (10)
Anagnostopoulos, Ach ... (10)
Strefford, Jonathan ... (10)
Davi, F (9)
Plevova, K. (9)
Hadzidimitriou, Anas ... (9)
Yan, Xiao-Jie (9)
Cahill, Nicola (9)
Mattsson, Mattias (9)
Stavroyianni, Niki (9)
Davis, Z (8)
Oscier, D. (8)
Sander, Birgitta (7)
Stamatopoulos, K (7)
Agathangelidis, A (7)
Panagiotidis, P. (7)
Pedersen, Lone Bredo (7)
Smedby, K E (7)
Rosenquist, Richard ... (7)
Trentin, Livio (7)
visa färre...
Lärosäte
Uppsala universitet (75)
Karolinska Institutet (46)
Lunds universitet (30)
Göteborgs universitet (5)
Umeå universitet (5)
Linköpings universitet (3)
visa fler...
Stockholms universitet (1)
visa färre...
Språk
Engelska (81)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (74)
Naturvetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy